中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Issue 7
Jul.  2018

Specific magnetic resonance imaging of vascular endothelial growth factor-C targeted molecular probe and its clinical significance in a rat model of hepatocellular carcinoma

DOI: 10.3969/j.issn.1001-5256.2018.07.025
Research funding:

 

  • Received Date: 2018-01-25
  • Published Date: 2018-07-20
  • Objective To investigate the magnetic resonance ( MR) imaging features of the targeted molecular probe with vascular endothelial growth factor-C ( VEGF-C) antibody and superparamagnetic iron oxide ( USPIO) , VEGF-C-USPIO, in a rat model of hepatocellular carcinoma ( HCC) and its clinical significance. Methods The induction method was used to establish a rat model of in situ HCC, and30 Sprague-Dawley rats were randomly divided into experimental group with 20 rats and control group with 10 rats. The rats in the experimental group were treated with tail vein injection of the targeted molecular probe VEGF-C-USPIO, and those in the control group were treated with tail vein injection of the non-targeted probe USPIO. MR scanning was performed before injection and at 1 hour after injection;the intensity of T2 WI signal in liver tumor and adjacent liver tissue was measured; contrast-to-noise ratio ( CNR) was calculated, and the two groups were compared in terms of CNR before and after enhancement. Liver tissue was collected after scanning, and HE staining was performed to clarify the pathological type of liver cancer in rats; Prussian blue staining was performed to analyze the content of iron in tumor cells; immunohistochemical staining was performed to investigate the expression of VEGF-C in liver cancer tissue. The independent samples t-test was used for comparison between the experimental group and the control group, and the paired samples t-test was used for comparison within each group after the injection of contrast agent. Results Cancer was successfully induced in all 30 rats; the pathological diagnosis was HCC, and the tumor formation rate was 100%. The experimental group had a significant change in CNR at 1 hour after the injection of the targeted contrast agent VEGF-C-USPIO ( 2. 11 ± 0. 23 vs 3. 47 ± 0. 45, t =-13. 15, P < 0. 001) , while the control group had no significant change in CNR at 1 hour after the injection of the non-targeted contrast agent USPIO ( 3. 51 ± 0. 14 vs 3. 82 ± 0. 61, t =-1. 40, P = 0. 192) ; there was a significant difference in CNR between the two groups after injection ( t = 17. 60, P < 0. 001) . HE staining performed for liver tissue samples showed a pathological type of HCC; immunohistochemical staining showed that VEGF-C was mainly expressed in the membrane and cytoplasm of hepatoma cells; Prussian blue staining showed that compared with the control group, the experimental group had a significant increase in iron particles in tumor tissue. Conclusion The synthesized targeted molecular probe VEGF-C-USPIO has a good active targeting effect on a rat model of HCC and can realize the specific imaging of HCC through the change in MR signal intensity. Therefore, it provides an imaging basis for the early diagnosis of HCC.

     

  • [1]SIEGEL RL, MILLER KD, JEMAL A.Cancer statistics, 2016[J].CA Cancer J Clin, 2016, 66 (1) :7-30.
    [2]CHOU R, CUEVAS C, FU R, et al.Imaging techniques for the diagnosis of hepatocellular carcinoma:A systematic review and meta-analysis[J].Ann Intern Med, 2015, 162 (10) :697-711.
    [3]ZHANG CY, FU Y, LI XD, et al.Advances in imaging diagnosis of liver cancer[J].J Clin Hepatol, 2017, 33 (7) :1266-1269. (in Chinese) 张春雨, 付宇, 李晓东, 等.肝癌的影像学诊断进展[J].临床肝胆病杂志, 2017, 33 (7) :1266-1269.
    [4]International Consensus Group for Hepatocellular Neoplasia.Pathologic diagnosis of early hepatocellular carcinoma:A report of the international consensus group for hepatocellular neoplasia[J].Hepatology, 2009, 49 (2) :658-664.
    [5]LIU J, CHENG Y, HE M, et al.Vascular endothelial growth factor C enhances cervical cancer cell invasiveness via upregulation of galectin-3 protein[J].Gynecol Endocrinol, 2014, 30 (6) :461-465.
    [6]SONG JH, YU DX, FANG JJ, et al.Specific MR imaging of hepatocellular carcinoma using AFP-targeted USPIO molecular probe[J].Chin J Hepatobiliary Surg, 2012, 18 (8) :618-622. (in Chinese) 宋吉慧, 于德新, 方娟娟, 等.甲胎蛋白靶向USPIO分子探针在肝癌特异性磁共振成像中的价值[J].中华肝胆外科杂志, 2012, 18 (8) :618-622.
    [7]EFFENDI K, SAKAMOTO M.Molecular pathology in early hepatocarcinogenesis[J].Oncology, 2010, 78 (2) :157-160.
    [8]MA L, JI L, YU Y, et al.Novel molecular targets for diagnosis and treatment of hepatocellular carcinoma[J].Discov Med, 2015, 19 (102) :7-14.
    [9] JEMAL A, BRAY F, CENTER MM, et al.Global cancer statistics[J].CA Cancer J Clin, 2011, 61 (2) :69-90.
    [10]BHARALI DJ, MOUSA SA.Emerging nanomedicines for early cancer detection and improved treatment:Current perspective and future promise[J].Pharmacol Ther, 2010, 128 (2) :324-335.
    [11]OGHABIAN MA, FARAHBAKHSH NM.Potential use of nanoparticle based contrast agents in MRI:A molecular imaging perspective[J].J Biomed Nanotechnol, 2010, 6 (3) :203-213.
    [12]MA KS, JIANG JY.Application of tissue-specific magnetic resonance imaging contrast agent gadolinium ethoxybenzyl dimeglumine on precision hepatic surgery[J].Chin J Dig Surg, 2017, 16 (2) :124-129. (in Chinese) 马宽生, 蒋家云.钆塞酸二钠增强MRI检查在精准肝脏外科中的应用[J].中华消化外科杂志, 2017, 16 (2) :124-129.
    [13]SUN Y, ZHENG YY, WU W, et al.Influence of superparamagnetic iron oxide loaded polymermicrospheres on enhanced MRI for liver cancer of rabbits[J].Chin J Med Imaging Technol, 2012, 28 (8) :1445-1448. (in Chinese) 孙阳, 郑元义, 吴伟, 等.载超顺磁性氧化铁高分子微球对兔肝癌MR成像效果的影响[J].中国医学影像技术, 2012, 28 (8) :1445-1448.
    [14]ISLAM T, JOSEPHSON L.Current state and future applications of active targeting in malignancies using superparamagnetic iron oxide nanoparticles[J].Cancer Biomark, 2009, 5 (2) :99-107.
    [15]YAMAGUCHI R, YANO H, NAKASHIMA O, et al.Expression of vascular endothelial growth factor-C in human hepatocellular carcinoma[J].J Gastroenterol Hepatol, 2006, 21 (1 Pt 1) :152-160.
    [16]MORITA Y, MORITA N, HATA K, et al.Cyclooxygenase-2 expression is associated with vascular endothelial growth factor-c and lymph node metastasis in human oral tongue cancer[J].Oral Surg Oral Med Oral Pathol Oral Radiol, 2014, 117 (4) :502-510.
    [17]CHEN Y, ZHOU Q, LI X, et al.Ultrasmall paramagnetic iron oxide nanoprobe targeting epidermal growth factor receptor for in vivo magnetic resonance imaging of hepatocellular carcinoma[J].Bioconjug Chem, 2017, 28 (11) :2794-2803.
    [18]JIANG AL, GUO ZB, DING ZX.Expression and significance of VEGF-C in human hepatocellular carcinoma tissues[J].Chin J Cancer Prev Treat, 2009, 16 (13) :1006-1008. (in Chinese) 姜爱莲, 郭子博, 丁兆习.VEGF-C在人原发性肝细胞肝癌中的表达及意义[J].中华肿瘤防治杂志, 2009, 16 (13) :1006-1008.
  • Relative Articles

    [1]Wei YU, Chengbin ZHANG, Yan MA. A case of primary carcinosarcoma of the liver[J]. Journal of Clinical Hepatology, 2021, 37(12): 2890-2890. doi: 10.3969/j.issn.1001-5256.2021.12.030
    [2]Jiamin ZHAO, Zhiyuan CHEN, Chengliang DING, Lili YUAN, Jingjing QIAN, Chunyang XU, Lingyun ZUO. Primary biliary cholangitis with hepatic angiosarcoma: A case report[J]. Journal of Clinical Hepatology, 2021, 37(10): 2411-2413. doi: 10.3969/j.issn.1001-5256.2021.10.031
    [3]Mengnan LI, Gongchen WANG, Zhiming ZHANG. A case of hepatic angiosarcoma with Kasabach-Merritt syndrome[J]. Journal of Clinical Hepatology, 2021, 37(11): 2646-2648. doi: 10.3969/j.issn.1001-5256.2021.11.032
    [4]Huijun WANG, Jianxiang NIU, Xiaoyan XU, Weihua ZHENG, Pengfei LI, Yibo LIU, Junjing ZHANG. A case of primary splenic angiosarcoma[J]. Journal of Clinical Hepatology, 2021, 37(11): 2655-2657. doi: 10.3969/j.issn.1001-5256.2021.11.036
    [5]Li Dong, Luo TianYang, Ran YaWei. Value of contrast-enhanced computed tomography and magnetic resonance imaging in diagnosis of residual or recurrent lesion after transcatheter arterial chemoembolization in hepatocellular carcinoma:A Meta-analysis[J]. Journal of Clinical Hepatology, 2019, 35(10): 2214-2219. doi: 10.3969/j.issn.1001-5256.2019.10.017
    [6]Zhang XueWen, Dai ChaoLiu. Primary hepatic angiosarcoma in the elderly: A case report and literature review[J]. Journal of Clinical Hepatology, 2019, 35(3): 605-607. doi: 10.3969/j.issn.1001-5256.2019.03.031
    [7]Zhu XiXun, Li ZhiWei, Zheng Yu. A case of primary hepatic angiosarcoma with splenic metastasis and rupture[J]. Journal of Clinical Hepatology, 2019, 35(3): 608-610. doi: 10.3969/j.issn.1001-5256.2019.03.032
    [8]Wang ShuPeng, Han KaiZe, Wang Wu, Yang Yang, Liu YaHui. Spontaneous rupture of splenic angiosarcoma: 2 cases report[J]. Journal of Clinical Hepatology, 2018, 34(12): 2670-2671. doi: 10.3969/j.issn.1001-5256.2018.12.035
    [9]Huang Lu, Lu LiJian. CT and MRI manifestations of liver fluke granuloma[J]. Journal of Clinical Hepatology, 2017, 33(8): 1548-1551. doi: 10.3969/j.issn.1001-5256.2017.08.028
    [10]Du XiaoFeng, Ma ZhouPeng, Lin GuanSheng, He Hui, Tang YaRong, Wu JianMing. CT diagnosis and differentiation of nodular/mass-type hepatic lymphoma[J]. Journal of Clinical Hepatology, 2017, 33(8): 1492-1496. doi: 10.3969/j.issn.1001-5256.2017.08.016
    [11]Zhang YiWei, Zhang Wei, Liu Feng, Liu YaHui. Laparoscopic splenectomy in treatment of splenic angiosarcoma: a case report[J]. Journal of Clinical Hepatology, 2017, 33(4): 744-745. doi: 10.3969/j.issn.1001-5256.2017.04.034
    [12]Li XinMing, Quan XianYue, Tan ShuPing. Imaging feature of rare liver neoplasms[J]. Journal of Clinical Hepatology, 2016, 32(12): 2289-2294. doi: 10.3969/j.issn.1001-5256.2016.12.012
    [13]Zhai YaNan, Li Lei, Yin Liang, Guo QiHong, Lei JunQiang, Guo ShunLin, Zhang ChunYu, Wang HaiJun, Wen XiaoXiao. Role of dual-source CT low-dose whole liver perfusion imaging in evaluating liver blood perfusion after transjugular intrahepatic portosystemic shunt in cirrhotic patients with portal hypertension[J]. Journal of Clinical Hepatology, 2016, 32(10): 1894-1899. doi: 10.3969/j.issn.1001-5256.2016.10.014
    [14]Ke JianJi, Liu FeiQi, Zhang Wei, Liu YaHui. One case of huge hepatic angiosarcoma[J]. Journal of Clinical Hepatology, 2015, 31(11): 1902-1903. doi: 10.3969/j.issn.1001-5256.2015.11.034
    [15]Liu BinBin, Wang YuHong. Values of MRI and CT in diagnosis and treatment of acute pancreatitis[J]. Journal of Clinical Hepatology, 2013, 29(7): 489-491. doi: 1001-5256 (2013) 07-0489-03
    [16]Yan FuHua, Luo XianFu. Research progress in CT and MR for quantitative diagnosis of liver fibrosis[J]. Journal of Clinical Hepatology, 2013, 29(10): 732-735. doi: 10.3969/j.issn.1001-5256.2013.10.003
    [17]Zhao ChunHua, Zhou WenFeng, Chen WeiHua, Xi Zhen, Zhang ChunMei. Clinical significance of α- fetoprotein in initial diagnosis of primary hepatic cancer[J]. Journal of Clinical Hepatology, 2013, 29(9): 698-701. doi: 10.3969/j.issn.1001-5256.2013.09.017
    [18]Liang Liang, Lu XiuLiang, Gu JunYing, Chen Gang, Rao ShengXiang, Ji Yuan, Ceng MengSu. Imaging characteristics of abdominal organs in autoimmune pancreatitis[J]. Journal of Clinical Hepatology, 2012, 28(8): 579-583.
    [19]Liu Qin, Qiao XiuLi, Gao XiaoZhong, Shao ChunZhong. The importance of regular follow-up for early detection of hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2010, 26(3): 306-307+309.
  • Created with Highcharts 5.0.7Amount of accessChart context menuAbstract Views, HTML Views, PDF Downloads StatisticsAbstract ViewsHTML ViewsPDF Downloads2024-052024-062024-072024-082024-092024-102024-112024-122025-012025-022025-032025-04051015202530
    Created with Highcharts 5.0.7Chart context menuAccess Class DistributionFULLTEXT: 1.6 %FULLTEXT: 1.6 %META: 94.9 %META: 94.9 %PDF: 3.5 %PDF: 3.5 %FULLTEXTMETAPDF
    Created with Highcharts 5.0.7Chart context menuAccess Area Distribution其他: 6.8 %其他: 6.8 %其他: 0.2 %其他: 0.2 %Bass Hill: 0.2 %Bass Hill: 0.2 %Central District: 0.6 %Central District: 0.6 %China: 0.2 %China: 0.2 %India: 0.2 %India: 0.2 %Seattle: 0.2 %Seattle: 0.2 %上海: 2.3 %上海: 2.3 %中卫: 0.4 %中卫: 0.4 %丽水: 0.4 %丽水: 0.4 %佛山: 0.4 %佛山: 0.4 %北京: 7.6 %北京: 7.6 %北伯根: 0.2 %北伯根: 0.2 %南京: 1.0 %南京: 1.0 %南宁: 0.2 %南宁: 0.2 %南平: 0.2 %南平: 0.2 %台北: 0.2 %台北: 0.2 %台州: 2.7 %台州: 2.7 %吉林: 0.8 %吉林: 0.8 %哥伦布: 0.4 %哥伦布: 0.4 %大连: 0.6 %大连: 0.6 %天津: 0.8 %天津: 0.8 %太原: 0.2 %太原: 0.2 %宿迁: 0.2 %宿迁: 0.2 %布里斯班: 0.2 %布里斯班: 0.2 %常德: 0.2 %常德: 0.2 %平顶山: 0.2 %平顶山: 0.2 %广州: 0.2 %广州: 0.2 %张家口: 2.9 %张家口: 2.9 %昆明: 0.6 %昆明: 0.6 %杭州: 1.4 %杭州: 1.4 %武汉: 0.2 %武汉: 0.2 %沈阳: 0.2 %沈阳: 0.2 %洛阳: 0.2 %洛阳: 0.2 %济南: 0.2 %济南: 0.2 %淄博: 0.2 %淄博: 0.2 %深圳: 0.6 %深圳: 0.6 %湖州: 1.6 %湖州: 1.6 %芒廷维尤: 27.3 %芒廷维尤: 27.3 %苏州: 0.2 %苏州: 0.2 %莫斯科: 1.6 %莫斯科: 1.6 %衢州: 2.5 %衢州: 2.5 %西宁: 28.5 %西宁: 28.5 %西安: 0.2 %西安: 0.2 %赣州: 0.6 %赣州: 0.6 %辽阳: 0.2 %辽阳: 0.2 %运城: 0.2 %运城: 0.2 %邯郸: 0.2 %邯郸: 0.2 %郑州: 0.2 %郑州: 0.2 %金华: 1.0 %金华: 1.0 %银川: 0.2 %银川: 0.2 %长春: 1.0 %长春: 1.0 %长沙: 0.6 %长沙: 0.6 %其他其他Bass HillCentral DistrictChinaIndiaSeattle上海中卫丽水佛山北京北伯根南京南宁南平台北台州吉林哥伦布大连天津太原宿迁布里斯班常德平顶山广州张家口昆明杭州武汉沈阳洛阳济南淄博深圳湖州芒廷维尤苏州莫斯科衢州西宁西安赣州辽阳运城邯郸郑州金华银川长春长沙

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Article Metrics

    Article views (2181) PDF downloads(346) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return